|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Crux_Biomedical
gptkb:Bard_Medical
gptkb:CareFusion_Corporation
gptkb:Surgical_Specialties_Corporation
Cypress_Diagnostics
|
|
gptkbp:CEO
|
gptkb:Tom_Polen
Vincent A. Forlenza
|
|
gptkbp:communityEngagement
|
Disaster relief efforts
Health education programs
Health fairs
Local partnerships
Employee volunteer programs
|
|
gptkbp:employees
|
approximately 70,000
|
|
gptkbp:focusArea
|
Research and development
Medication management
Surgical instruments
Diagnostics
Infection prevention
|
|
gptkbp:founded
|
1897
|
|
gptkbp:founder
|
gptkb:William_Dickinson
gptkb:Maxwell_Becton
|
|
gptkbp:globalPresence
|
Over 50 countries
|
|
gptkbp:headCoach
|
70,000
70,000 (2022)
|
|
gptkbp:headquarters
|
gptkb:Franklin_Lakes,_New_Jersey,_USA
gptkb:Franklin_Lakes,_New_Jersey
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Becton, Dickinson and Company
|
|
gptkbp:industry
|
Medical technology
|
|
gptkbp:innovation
|
gptkb:Robotic_surgery_systems
Point-of-care testing
Automated blood culture systems
Smart syringe technology
Research_and_Development
Digital_health_solutions
|
|
gptkbp:market
|
$70 billion (2022)
|
|
gptkbp:partnerships
|
gptkb:Global_Fund
gptkb:World_Health_Organization
gptkb:American_Red_Cross
gptkb:Gavi,_the_Vaccine_Alliance
gptkb:CDC_Foundation
|
|
gptkbp:patentCitation
|
Over 10,000 patents
|
|
gptkbp:philanthropy
|
BD_Foundation
|
|
gptkbp:products
|
Needles
Syringes
Blood collection systems
Diagnostic instruments
|
|
gptkbp:revenue
|
$17.1 billion (2022)
|
|
gptkbp:stockSymbol
|
BDX
|
|
gptkbp:subsidiary
|
gptkb:BD_Medical
BD Biosciences
BD Diagnostics
|
|
gptkbp:sustainability
|
Sustainable Development Goals
|
|
gptkbp:sustainabilityInitiatives
|
Environmental sustainability
Social responsibility
Governance practices
|
|
gptkbp:tradedOn
|
gptkb:New_York_Stock_Exchange
|
|
gptkbp:website
|
www.bd.com
|